Federal regulators are set to unveil a new Medicare coverage pathway aimed at accelerating access to FDA-designated breakthrough medical devices, enhancing treatment options for patients.
In a recent shift, RFK Jr. has expressed support for vaccinations while also defending his previous secret agreements with pharmaceutical companies.
The Nuclear Energy Agency (NEA) recently convened a workshop to explore advancements and challenges in the supply of medical radioisotopes.
A recent discovery by researchers at the University of Toronto reveals that certain bacteria can transform waste into valuable chemicals, potentially transforming the cosmetics industry.
In a notable shift, Kennedy is adjusting his approach to MAHA, stepping back from several key issues while still making an impact in health care.
The appointment of a former Imperial Brands executive to a senior position at the CDC has sparked concerns about potential tobacco industry influence within the agency.
Robert F. Kennedy Jr. is set to testify before the Senate's health care panel today. Viewers can watch the proceedings live as he addresses the committee.
Stay informed with the latest developments in the biotech sector, featuring updates on RevMed, Roche, and Kyverna's CAR-T therapy.
As summer approaches, it's essential to be aware of Vibrio, a bacteria present in coastal waters and raw shellfish, to ensure safe beach outings and seafood consumption.
The rise of MAHA snacks, from protein-infused Pop-Tarts to avocado-oil chips, suggests a shift towards healthier eating. However, nutrition experts caution that the benefits may be overstated.
Thomas Goetz emphasizes that each drug represents a broader narrative involving health, medicine, society, and economics.
The CDC’s Epidemic Intelligence Service has reached a significant milestone, having trained over 4,300 individuals who are now integral to public health efforts.
Roche is advancing its experimental multiple sclerosis drug to regulators following successful trials, though significant safety concerns persist.
A recent study has mapped 55,000 genes in roses, which are vital ornamental plants. This research could significantly influence breeding practices, as currently, less than 10% of rose species are utilized.
In a notable move, key Republican senators are likely to oppose President Trump's proposed cuts to the National Institutes of Health and the reorganization of Health and Human Services for the second consecutive year.
As the leading donor in global health, the U.S. government allocates its budget across several critical program areas, including HIV, tuberculosis, and malaria.
A judge is anticipated to impose a $225 million forfeiture on Purdue Pharma, the maker of OxyContin, facilitating the completion of its settlement with the Justice Department.
A U.S. judge is anticipated to order Purdue Pharma to forfeit $225 million, marking a significant step in ongoing legal proceedings.
Recent developments indicate that a CDC conference, previously open to the public, may now have restricted access. This follows a federal ruling related to gender declaration and highlights ongoing issues in health policy.
KFF is set to debut a podcast hosted by Chip Kahn, focusing on the intricate relationship between health policy and business. The initiative aims to deepen understanding of these complexities.